agree.The market cap is $60m, while cash is $30m (after debt). It’s hard to image theremaining asset of the company is worth only $30m.
https://starpharma.com/technology
It’s far better to buy a wonderfulcompany at fair price, than a fair company at wonderful price.
time will tell if SPL is a wonderfulcompany. Its technology seems substantially value-adding to improvepharmaceutical product performance etc. we have already seen a fewcommercialisation of the technology.
if it can utilise it’s technology insubstantial, substantive application , like the way MRNA changes vaccines. Itwould be wonderful.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
9.8¢ |
Change
-0.002(2.00%) |
Mkt cap ! $40.98M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.7¢ | $3.09K | 30.94K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16397 | 9.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 24393 | 1 |
View Market Depth
| Last trade - 15.32pm 11/07/2025 (20 minute delay) ? |
| SPL (ASX) Chart |